SCHEMBL717017

SCHEMBL717017

CCC1CCCCN1CC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
LMNA P02545 1/20 0.47
ALOX15 P16050 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
LTA4H P09960 1/20 0.47
ALDH1A1 P00352 2/20 0.43
TSHR P16473 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
TERT O14746 2/20 0.41
HSD17B10 Q99714 1/20 0.41
ATM Q13315 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MAPK1 P28482 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL499847 0.94 MEN1 (0.44) MEN1KMT2ALMNAALOX15CRHBP
Fluorobenzene SCHEMBL27853091 0.85 LMNA (0.52) MEN1KMT2ALMNAALOX15CRHBP
Malonic Acid SCHEMBL28164983 0.84 ALDH1A1 (0.50) MEN1KMT2ALMNAALOX15CRHBP
SCHEMBL6050349 0.84 KMT2A (0.48) MEN1KMT2ALMNAALOX15CRHBP
SCHEMBL5014206 0.84 KMT2A (0.48) MEN1KMT2ALMNAALOX15CRHBP
SCHEMBL17266473 0.83 LTA4H (0.48) MEN1KMT2ALTA4HALDH1A1TERT
SCHEMBL9181496 0.82 TERT (0.51) MEN1KMT2ALTA4HTSHRTERT
SCHEMBL9678516 0.82 CYP1A2 (0.43) MEN1KMT2ALMNAALOX15CRHBP
SCHEMBL27767339 0.81 KMT2A (0.45) MEN1KMT2ALMNAALOX15CRHBP
SCHEMBL10508128 0.81 LTA4H (0.44) MEN1KMT2ALMNAALOX15CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119529132-A Modified chitosan derivative, nano-particles, preparation method and application 苏州大学 2025-02-28 CN disclosed
CN-108586723-A Polycondensation resin and optical film formed therefrom 三菱化学株式会社 2018-09-28 CN disclosed
CN-106062035-B Polycondensation resin and optical film formed therefrom 三菱化学株式会社 2018-05-29 CN disclosed
CN-106986748-A Oligofluorenediols, oligofluorenediaryl esters, and methods for producing these 三菱化学株式会社 2017-07-28 CN disclosed
CN-106062035-A Polycondensation resin and optical film formed therefrom 三菱化学株式会社 2016-10-26 CN disclosed
US-8586638-B2 Parakeratosis inhibitor and skin preparation for external use SHISEIDO COMPANY, LTD (JP) 2013-11-19 US disclosed
US-20120253064-A1 PARAKERATOSIS INHIBITOR AND SKIN PREPARATION FOR EXTERNAL USE SHISEIDO COMPANY, LTD. (JP) 2012-10-04 US disclosed
EP-2491980-A2 Parakeratosis inhibitor and skin preparation for external use SHISEIDO COMPANY LIMITED (JP) 2012-08-29 EP disclosed
EP-2491981-A2 Parakeratosis inhibitor and external composition for skin SHISEIDO COMPANY LIMITED (JP) 2012-08-29 EP disclosed
US-20120053243-A1 PARAKERATOSIS INHIBITOR AND SKIN PREPARATION FOR EXTERNAL USE SHISEIDO COMPANY, LTD. (JP) 2012-03-01 US disclosed
US-20070225380-A1 Parakeratosis Inhibitor and Skin Preparation for External use SHISEIDO COMPANY LTD. (JP) 2007-09-27 US disclosed
EP-1688126-A1 PARAKERATOSIS INHIBITOR AND EXTERNAL COMPOSITION FOR SKIN SHISEIDO COMPANY LIMITED (JP) 2006-08-09 EP disclosed
EP-0891362-B1 PYRROLOPYRROLONE DERIVATIVES AS INHIBITORS OF NEUTROPHIL ELASTASE GLAXO GROUP LTD (GB) 2004-03-17 EP disclosed
US-6215002-B1 CYCLIZATION, DEBLOCKING, DEPROTECTION, SULFONATION, CONDENSATION, AMIDATION; ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS GLAXO WELLCOME INC. 2001-04-10 US disclosed
US-6057457-A ENZYME INHIBITORS FOR PROTEASE OR ENZYMES OF HYDROLYSIS GLAXO WELLCOME INC. (US) 2000-05-02 US disclosed
US-5994344-A BRONCHITIS THERAPY GLAXO WELLCOME INC. (US) 1999-11-30 US disclosed
EP-0891362-A1 PYRROLOPYRROLONE DERIVATIVES AS INHIBITORS OF NEUTROPHIL ELASTASE GLAXO GROUP LIMITED (GB) 1999-01-20 EP disclosed
US-5808152-A Synthesis of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide using sodium formate BAYER CORPORATION (US) 1998-09-15 US disclosed
US-5808153-A Conversion of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide acetate to N-4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide BAYER CORPORATION 1998-09-15 US disclosed
WO-1997036903-A1 PYRROLOPYRROLONE DERIVATIVES AS INHIBITORS OF NEUTROPHIL ELASTASE GLAXO GROUP LIMITED (GB) 1997-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053243-A1 PARAKERATOSIS INHIBITOR AND SKIN PREPARATION FOR EXTERNAL USE CUTA, HPN, DNPEP MEN1 3026/4885KMT2A 1731/4885LMNA 147/4885
US-20120253064-A1 PARAKERATOSIS INHIBITOR AND SKIN PREPARATION FOR EXTERNAL USE CUTA, HPN, PRSS1 MEN1 3084/4885KMT2A 1713/4885LMNA 316/4885
US-20070225380-A1 Parakeratosis Inhibitor and Skin Preparation for External use CUTA, HPN, DNPEP MEN1 3026/4885KMT2A 1731/4885LMNA 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.